The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
The intestinal anti‐inflammatory effect of quercitrin is associated with an inhibition in iNOS expression
Open accessAbstract
Quercitrin, 3‐rhamnosylquercetin, is a bioflavonoid with antioxidant properties, which exerts anti‐inflammatory activity in experimental colitis. In the present study, different in vivo experiments were performed in order to evaluate the mechanisms of action involved in this effect, with special attention to its effects on proinflammatory mediators, including nitric oxide (NO). Experimental colitis was induced in female Wistar rats by incorporation of dextran sodium sulfate (DSS) in drinking water. Oral treatment of quercitrin (1 or 5 mg kg−1 day−1) to colitic rats ameliorated the evolution of the inflammatory process induced when administered in a preventative dosing protocol. When quercitrin (1 mg kg−1 day−1) was administered on established colitis, it facilitated the recovery of the inflamed mucosa. The beneficial effects exerted by quercitrin were evidenced both histologically and biochemically, and were associated with an improvement in the colonic oxidative status, altered as a consequence of the colonic insult induced by DSS. In addition, a reduction of colonic NO synthase activity was observed, probably related to a decreased expression in the inducible form of the enzyme via downregulation in the colonic activity of the nuclear factor‐κ B. Immunohistochemical studies showed that quercitrin treatment reduced macrophage and granulocyte infiltration in the inflamed tissue. British Journal of Pharmacology (2004) 143, 908–918. doi:10.1038/sj.bjp.0705941
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 4,979
Middleton, E., Kandaswami, C., & Theoharides, T. C. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01472-8 · Cited by 4,882
[70] Determination of glutathione and glutathione disulfide in biological samples
Anderson, M. E. (1985) · Methods in Enzymology · doi:10.1016/s0076-6879(85)13073-9 · Cited by 2,748
Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase.
Xie, Q. W., Kashiwabara, Y., & Nathan, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37600-7 · Cited by 2,212 · cited 1×
“According to the well-described role of NF-kB in inflammatory regulation (Schottelius & Baldwin, 1999) and in iNOS expression (Xie et al., 1994), the degree of NF-kB activation was determined in the colonic tissue samples from animals submitted to DSS administration for 15 days.”
MethodInflammatory bowel disease: Etiology and pathogenesis
Fiocchi, C. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70381-6 · Cited by 2,059
Clinicopathologic study of dextran sulfate sodium experimental acute colitis
Shichijo, K., Matuu, M., Ikeda, Y., Naito, S., Ito, M., & Sekine, I. (1998) · Japanese Journal of Pharmacology · doi:10.1016/s0021-5198(19)41298-5 · Cited by 1,943
Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity
Krawisz, J. E., Sharon, P., & Stenson, W. F. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90202-6 · Cited by 1,758
[36] Flavonoids as antioxidants: Determination of radical-scavenging efficiencies
Bors, W., Heller, W., Michel, C., & Saran, M. (1990) · Methods in Enzymology · doi:10.1016/0076-6879(90)86128-i · Cited by 1,723
Neurath, M. F., Pettersson, S., Meyer Zum Büschenfelde, K.-H., & Strober, W. (1996) · Nature Medicine · doi:10.1038/nm0996-998 · Cited by 840
Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease
Sharon, P., & Stenson, W. F. (1984) · Gastroenterology · doi:10.1016/s0016-5085(84)80015-3 · Cited by 738
Nuclear factor κB is activated in macrophages and epithelial cells of inflamed intestinal mucosa
Rogler, G., Brand, K., Vogl, D., Page, S., Hofmeister, R., Andus, T., Knuechel, R., Baeuerle, P. A., Schölmerich, J., & Gross, V. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70202-1 · Cited by 715
Kim, H. K., Cheon, B. S., Kim, Y. H., Kim, S. Y., & Kim, H. P. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00160-4 · Cited by 546
Oxidants and free radicals in inflammatory bowel disease
GRISHAM, M. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92831-2 · Cited by 525
Tsai, S., Lin‐Shiau, S., & Lin, J. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702357 · Cited by 511
Reuter, B. K., Asfaha, S., Buret, A., Sharkey, K. A., & Wallace, J. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119013 · Cited by 423
Aminoguanidine selectively inhibits inducible nitric oxide synthase
Griffiths, M. J. D., Messent, M., MacAllister, R. J., & Evans, T. W. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13907.x · Cited by 397
Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease
Pavlick, K. P., Laroux, F. S., Fuseler, J., Wolf, R. E., Gray, L., Hoffman, J., & Grisham, M. B. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00853-5 · Cited by 373
Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies.
Brattsand, R., & Linden, M. (1996) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1996.22164025.x · Cited by 359
Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease.
McKenzie, S. J., Baker, M. S., Buffinton, G. D., & Doe, W. F. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118757 · Cited by 349
OBERMEIER, F., KOJOUHAROFF, G., HANS, W., SCHÖLMERICH, J., GROSS, V, & FALK, W. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1999.00878.x · Cited by 317
Kim, H. P., Mani, I., Iversen, L., & Ziboh, V. A. (1998) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(98)90125-9 · Cited by 303
Anti–interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice
Fuss, I. J., Marth, T., Neurath, M. F., Pearlstein, G. R., Jain, A., & Strober, W. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70392-6 · Cited by 268
Dextran Sulfate Sodium (DSS) Colitis in Rats (Clinical, Structural, and Ultrastructural Aspects)
Gaudio, E., Taddei, G., Vetuschi, A., Sferra, R., Frieri, G., Ricciardi, G., & Caprilli, R. (1999) · Digestive Diseases and Sciences · doi:10.1023/a:1026620322859 · Cited by 254
Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity.
Rachmilewitz, D., Karmeli, F., Okon, E., & Bursztyn, M. (1995) · Gut · doi:10.1136/gut.37.2.247 · Cited by 191
A role for transcription factor NF- k B in intestinal inflammation
Schottelius, A. J. G., & Baldwin Jr., A. S. (1999) · International Journal of Colorectal Disease · doi:10.1007/s003840050178 · Cited by 188
Stucchi, A. F., Shofer, S., Leeman, S., Materne, O., Beer, E., McClung, J., Shebani, K., Moore, F., O'Brien, M., & Becker, J. M. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.279.6.g1298 · Cited by 175
The selective beneficial effects of nitric oxide inhibition in experimental colitis
Hogaboam, C. M., Jacobson, K., Collins, S. M., & Blennerhassett, M. G. (1995) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1995.268.4.g673 · Cited by 168
Comparative Tolerability of Treatments for Inflammatory Bowel Disease
Stein, R. B., & Hanauer, S. B. (2000) · Drug Safety · doi:10.2165/00002018-200023050-00006 · Cited by 167
Anti-Inflammatory Activity of Diosmin and Hesperidin in Rat Colitis Induced by TNBS
Crespo, M., Gálvez, J., Cruz, T., Ocete, M., & Zarzuelo, A. (1999) · Planta Medica · doi:10.1055/s-2006-960838 · Cited by 167
Self-citationKimura, H., Miura, S., Shigematsu, T., Ohkubo, N., Tsuzuki, Y., Kurose, I., Higuchi, H., Akiba, Y., Hokari, R., Hirokawa, M., et al. (1997) · Digestive Diseases and Sciences · doi:10.1023/a:1018849405922 · Cited by 164
Intestinal anti‐inflammatory activity of morin on chronic experimental colitis in the rat
Gálvez, J., Coelho, G. B., Crespo, M., Cruz, T., Rodríguez‐Cabezas, M. E., Concha, Á., Gonzalez, M., & Zarzuelo, A. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01133.x · Cited by 151
Self-citationThe production of reactive oxygen species by dietary flavonols
Canada, A. T., Giannella, E., Nguyen, T. D., & Mason, R. P. (1990) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(90)90022-b · Cited by 146
Rodríguez‐Cabezas, M. E., Gálvez, J., Lorente, M., Concha, Á., Camuesco, D., Azzouz, S., Osuna, A., Redondo, L., & Zarzuelo, A. (2002) · Journal of Nutrition · doi:10.1093/jn/132.11.3263 · Cited by 128
Self-citationNitric Oxide and Chronic Gut Inflammation: Controversies in Inflammatory Bowel Disease
Grisham, M. B., Pavlick, K. P., Laroux, F. S., Hoffman, J. M., Bharwani, S., & Wolf, R. E. (2002) · Journal of Investigative Medicine · doi:10.2310/6650.2002.33281 · Cited by 105
Oral administration of rutoside can ameliorate inflammatory bowel disease in rats
Cruz, T., Gálvez, J., Ocete, M. A., Crespo, M., de Medina, F. S., & Zarzuelo, A. (1998) · Life Sciences · doi:10.1016/s0024-3205(97)01164-8 · Cited by 103
Self-citationEffect of quercitrin on the early stages of hapten induced colonic inflammation in the rat
de Medina, F. S., Vera, B., Gálvez, J., & Zarzuelo, A. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01568-0 · Cited by 103
Self-citationLópez‐López, G., Moreno, L., Cogolludo, A. L., Galisteo, M., Ibarra, M., Duarte, J., Lodi, F., Tamargo, J. L., & Pérez‐Vizcaíno, F. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.4.851 · Cited by 97
Pathogenesis of inflammatory bowel disease
Katz, J., Itoh, J., & Fiocchi, C. (1999) · Current Opinion in Gastroenterology · doi:10.1097/00001574-199907000-00003 · Cited by 83
Salicylates for ulcerative colitis—their mode of action
Travis, S. P. L., & Jewell, D. P. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90042-6 · Cited by 63
Marteau, P. R. (2000) · Endoscopy · doi:10.1055/s-2000-142 · Cited by 46
Nitric Oxide Supplementation Ameliorates Dextran Sulfate Sodium-Induced Colitis in Mice
Salas, A., Gironella, M., Salas, A., Soriano, A., Sans, M., Iovanna, J., Pique, J. M., & Panés, J. (2002) · Laboratory Investigation · doi:10.1038/labinvest.3780454 · Cited by 41
Pharmacotherapeutic options in inflammatory bowel disease: an update.
Kho, Y., Pool, M. O., Jansman, F. G. A., & Harting, J. W. (2001) · Pharmacy World & Science · doi:10.1023/a:1011268302386 · Cited by 32
Cited by
Comalada, M., Camuesco, D., Sierra, S., Ballester, I., Xaus, J., Gálvez, J., & Zarzuelo, A. (2005) · European Journal of Immunology · doi:10.1002/eji.200425778 · Cited by 647
Self-citationQuercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats
Rivera, L., Morón, R., Sánchez, M., Zarzuelo, A., & Galisteo, M. (2008) · Obesity · doi:10.1038/oby.2008.315 · Cited by 473
Comalada, M., Ballester, I., Bailón, E., Sierra, S., Xaus, J., Gálvez, J., Medina, F. S. D., & Zarzuelo, A. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.07.016 · Cited by 440
Nair, M. P., Mahajan, S., Reynolds, J. L., Aalinkeel, R., Nair, H., Schwartz, S. A., & Kandaswami, C. (2006) · Clinical and Vaccine Immunology · doi:10.1128/cvi.13.3.319-328.2006 · Cited by 398
Flavonoids and their role in oxidative stress, inflammation, and human diseases
Jomova, K., Alomar, S. Y., Valko, R., Liska, J., Nepovimova, E., Kuca, K., & Valko, M. (2025) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111489 · Cited by 362
Metadata
- Authors
- Camuesco, D., Comalada, M., Rodríguez‐Cabezas, M. E., Nieto, A., Lorente, M. D., Concha, A., Zarzuelo, A., & Gálvez, J.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2004-12
- Volume
- 143
- Issue
- 7
- Pages
- 908-918
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2145515127
- Cited by
- 268
- References
- 42
- FWCI
- 5.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.